Gentian Violet Treatment for Hidradenitis Suppurativa

Phase 2 Withdrawn Wake Forest University Health Sciences

NaSingle-groupOpen-labelTreatment

Summary

This is a survey study being conducted to describe how subjects with Hidradenitis suppurativa (HS) respond to treatment with gentian violet. The study will rely primarily on qualitative survey responses and quantitative changes in skin appearance.

Timeline

Start: 2025-08
Primary completion: 2026-12
Completion: 2026-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HEXAMETHYL PARAROSANILINE	Small molecule	—	Topical

Gentian Violet Treatment for Hidradenitis Suppurativa

Summary

Timeline

Drugs

Indications